On May 22, 2025, Inogen (INGN, Financial) received a significant upgrade from the analyst firm Needham. The analyst, Mike Matson, has elevated the company's rating from a previous "Hold" to a current "Buy". This change reflects a more optimistic outlook for Inogen.
In addition to the rating upgrade, Needham has also set a new price target for Inogen (INGN, Financial). The price target is now announced at USD 12.00, marking a new valuation benchmark for the company's shares. This adjustment in the price target signifies an updated assessment of Inogen’s potential performance in the market.
Investors may look to this upgraded rating and adjusted price target as indicators of enhanced confidence in Inogen's future growth prospects, as suggested by Needham’s latest analysis.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Inogen Inc (INGN, Financial) is $7.00 with a high estimate of $7.00 and a low estimate of $7.00. The average target implies an upside of 17.45% from the current price of $5.96. More detailed estimate data can be found on the Inogen Inc (INGN) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Inogen Inc's (INGN, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Inogen Inc (INGN, Financial) in one year is $9.71, suggesting a upside of 62.92% from the current price of $5.96. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Inogen Inc (INGN) Summary page.
